Phase 1 chronic spinal cord injury Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

NVG-291 in Spinal Cord Injury Subjects

chronic spinal cord injurySpinal Cord InjuriesSubacute Spinal Cord Injury

NervGen Pharma40 enrolled1 locationNCT05965700

Recruiting

Phase 1Phase 2

First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

chronic spinal cord injurySpinal Cord Injury

Yonsei University9 enrolled1 locationNCT06922890